Pfizer and the Challenges of the Global Pharmaceutical Industry

In: Business and Management

Submitted By maricelat
Words 582
Pages 3
Pfizer and the Challenges of the Global Pharmaceutical Industry
Case Study



Introduction
This report is to summarize the results of Pfizer’s challenges on global pharmaceutical industry and analyze driving factors of competition. I briefly give the industry definition describing the scope of the analysis. The paper has the following major goals:

1) To analyze the current situation, major competition challenges and the prospects of the pharmaceutical industry;
2) To assess Pfizer’s position as a major players of the global pharmaceutical industry and make a comparative analysis of other business practices and financial results using the VRIO method;
3) To recommend Kindler opportunities for further strengthening of their positions by conducting Porter 5 forces.

Pharmaceutical Industry Overview
Historically, the pharmaceutical industry has developed, produced and marketed one of the most profitable and high margin drugs for many years. This industry has gone through substantial changes in the last few decade and pharmaceutical firms face major challenges, including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex public policy issues.
Competition Challenges and Prospects
A firm must develop a product-market diversification strategy otherwise it may face substantial setbacks once the product loses momentum. It’s important to know- what percentages of revenue do pharmaceutical companies get for each product segment. Table 1.1 contains information about these major pharmaceutical companies that are sorted in the order of their 2007 revenues from the sales of pharmaceutical products.
Table 1.1. Major pharmaceutical companies Analysis.
Company | Location | Total Revenue | Product | Product Profit in Million, USD |…...

Similar Documents

Pfizer and the Challenges of the Global Pharmaceutical Industry

...Pfizer and the Challenges of the Global Pharmaceutical Industry Case Study Introduction This report is to summarize the results of Pfizer’s challenges on global pharmaceutical industry and analyze driving factors of competition. I briefly give the industry definition describing the scope of the analysis. The paper has the following major goals: 1) To analyze the current situation, major competition challenges and the prospects of the pharmaceutical industry; 2) To assess Pfizer’s position as a major players of the global pharmaceutical industry and make a comparative analysis of other business practices and financial results using the VRIO method; 3) To recommend Kindler opportunities for further strengthening of their positions by conducting Porter 5 forces. Pharmaceutical Industry Overview Historically, the pharmaceutical industry has developed, produced and marketed one of the most profitable and high margin drugs for many years. This industry has gone through substantial changes in the last few decade and pharmaceutical firms face major challenges, including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex public policy issues. Competition Challenges and Prospects A firm must develop a product-market diversification strategy otherwise it may face substantial setbacks once the product loses momentum. It’s...

Words: 582 - Pages: 3

Introduction to the Pharmaceutical Industry

...Introduction Discovering and bringing one new drug to the public typically costs a pharmaceutical or biotechnology company from £800 million to more than £1 billion and takes an average of 10 to 15 years. The drug discovery and development process is designed to ensure that only those pharmaceutical products that are both safe and effective are brought to market. PPD provides a broad array of drug discovery and development services and products to pharmaceutical, biotechnology and medical device companies to expedite drug development, from drug discovery through clinical studies and post-approval support. New drugs begin in the laboratory with scientists, including chemists and pharmacologists, who identify cellular and genetic factors that play a role in specific diseases. They search for chemical and biological substances that target these biological markers and are likely to have drug-like effects. Out of every 5,000 new compounds identified during the discovery process, approximately five are considered safe for testing in human volunteers after preclinical evaluations. After three to six years of further clinical testing in patients, only one of these compounds on average is ultimately approved as a marketed drug for treatment. The following sequence of research activities begins the process that results in development of new medicines: •Target Identification. Drugs usually act on either cellular or genetic chemicals in the body, known as targets, which are...

Words: 516 - Pages: 3

Top Ten Global Pharmaceutical Companies

...Market intelligence > Top ten global pharma Top ten global pharma Dr Vishal Agrawal, project manager, and Sunehli Jamwal, analyst, from GlobalData, highlight the top ten pharmaceutical companies by 2011 revenue. Pfizer 1 Johnson & Johnson 2 US pharmaceutical giant Pfizer maintained its top position in 2011 with stipulated revenue of $67.4 billion, up by 1% compared with $67.1 billion in 2010. The company’s new marketing strategy, coupled with focused organisational, financial and R&D restructuring efforts, compensated for the losses caused by Lipitor’s patent expiry. The approval of Xalkori for lung cancer, Inlyta and pneumococcal vaccine Prevnar 13 have proved to be a real lifeline for Pfizer. Moving ahead, the steady progress of the late-stage pipeline (with 22 projects in phase III and 11 under registration) will be a primary source of confidence for the company. The key strategy of the group is now to advance experimental drugs towards approval: these include Bosutinib, Tofacitinib, experimental clot-preventing drug Eliquis and its many pipeline drugs to make up for the inevitable decline in Lipitor revenue. With a view to reducing costs, Pfizer’s huge research budget has been cut by 12%. In 2012, Pfizer will focus on small to mid-sized deals and effective research partnerships to strengthen its portfolio in all therapeutic segments. Johnson & Johnson (J&J) reported 2011 revenues of $65 billion, a 5.6% increase over 2010. In 2011, the company...

Words: 1560 - Pages: 7

Global Pharmaceutical Industry

...Title: Strategy, Process, Content, Context, an international perspective Authors: Bob de wit en Ron Meyer Third edition Chapter 6,7,8 and 11 (each chapter also contains two readings) Chapter 6 Corporate level strategy Firms have a lot of growth options, while staying within the boundaries of a single business or broaden their scope even further through venturing into other lines of business and becoming multi-business corporations. Vertical integration: when a firm enters other businesses upstream or downstream within its own industry column. It can strive for backward integration by getting involved in supplier businesses or it can initiate forward integration by entering the businesses of its buyers. Horizontal integration: if the firm integrate related businesses at the same tier in the industry column. (Horizontal) diversification: if a firm expands outside of its current industry. The issue of corporate configuration: the issue of deciding on the best array of businesses and relating them to one another. Determining this can be disentangled into two main questions: 1. What business should the corporation be active in? (corporate composition. 2. How should this group of business be managed? (corporate management). Corporate composition This can be divided into: - corporate scope (how many businesses) - corporate distribution (the relative size of the activities in each business are covered) A common way of...

Words: 6481 - Pages: 26

The Global Pharmaceutical Industry: Conduct an External Analysis

... economic importance, government offer special incentives which encourage to the industry to globalisation. For example GSK increase their operations in Singapore due to low taxes and others government support. Same like, United States purchase more than 45% of drugs, the main reason is to allow foreign industry to compete with local which may help to low prices and reduce health budget. (David Floyd, 2008) From 1980 governments focused on pharmaceutical industry to handle the challenges of price control, monopoly and trade. For example in the European countries like Spain, Portugal, France and Italy the pharmaceutical market is cheap and thus these countries are used to ship their products to UK, Germany and Sweden for high price market. In US the price of pharmaceutical goods are high as compared to neighbour's country Canada due to the lake of price control. Like in US Lipitor (cloistral medicine) were sold with $3.20 per pill in 2003 as that of $1.89 per pill in Canada. (Sarah Holland Jul 2004 ) Environment Environment movements are real threats for Pharmaceutical industry as these movements focus on green environments and reduce chemicals and carbon which comes from pharmaceutical industries. It is not being possible to ignore these issues as they are supposed to be practiced under United Nation charter for clean and better environment. For example Pfizer is a well reputed British Pharmaceutical company which has aims to save the environment as much as possible from...

Words: 2635 - Pages: 11

Economics of the Pharmaceutical Industry

... ------------------------------------------------- Economics of the Pharmaceutical Industry Some of the factors affecting Supply in the Pharmaceutical Industry September 18, 2013 MBA BATcH 8 Prepared by: Amel Mohamed, Muna Abbas & Wafaa Gaafer September 18, 2013 MBA BATcH 8 Prepared by: Amel Mohamed, Muna Abbas & Wafaa Gaafer The well-being of the pharmaceutical industry is dependent largely on the economy. It is also a heavily regulated industry. Drugs are evaluated for safety, efficiency, and manufacturing quality as a condition of market access, and promotional messages must adhere to approved product characteristics. Drug prices also are regulated in most countries with national health insurance systems. The main factor that affects the industry is employment because a majority of Sudanese receive health insurance through their employers. Other economic factors such as the number of people who are uninsured or underinsured, performance and industry structure, the effects of regulation on prices, availability and utilization of drugs and productivity as well as the government stimulus plans also affects the industry. Unemployment Paramount to any industry is the number of people who are unemployed. In the first decade of the 20th century, this became a major political issue in the United States. Unemployment affects the pharmaceutical industry in two major ways. First, people who do not have jobs usually do not have the funds to buy the...

Words: 683 - Pages: 3

Indian Pharmaceutical Industry

...Indian Pharmaceutical Industry The Indian pharmaceutical industry has seen tremendous growth in the last decades and is one of the fastest growing pharmaceutical markets in the world. It is the fourth largest pharmaceutical market in the Asia Pacific region behind Japan, China and South Korea. However, the per capita spending of US$12 is among the lowest in the world, similar to levels in Pakistan and Vietnam. .India accounts for almost 10% of the global market by volume and is rapidly emerging as the leading outsourcing partner of global pharmaceutical companies, strengthened by improving Research and Development (R&D) focus and strategic position in the pharmaceutical value chain. The Industry structure of Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units with severe price competition and government price control. There are about 3,000 pharmaceutical manufacturers, the vast majority of which focus on generic drugs. The major players in the industry are Ranbaxy, Cipla, Dr. Reddy's Laboratories, Lupin, Nicolas Piramal,Aurobindo Pharma, Cadila Pharmaceuticals, Sun Pharma, W Wockhardt Ltd. and Aventis Pharma. The industry encourages international interest because of the growing population and economic improvements . Furthermore, initiatives of the Government such as allowing 100% FDI under the automatic route in drugs and pharmaceuticals including those involving use of recombinant technology act as a catalyst for......

Words: 257 - Pages: 2

The Global Pharmaceutical Industry

... SUBSTITUTES Threat of substitutes is high in these industries, there are many substitute products in market like generics, branded generics, biopharmaceuticals as they are very cheap compare to the branded drugs COMPETITIVE RIVALRY Competitive rivalry is high because the first mover gains advantage whereas the market is getting flooded with the worldwide launches, global branding and heavy investment in promotion. In spite of taking care during launching the industry is still faces tough time from generic medicines and not only this merges and acquisitions as one of the major cause for competitive rivalry. Q2. Conduct an industry by identifying the trends within the pharmaceutical industry based on the case itself. By September 2008 Pfizer took the world business as he was the number 1 with 13billion revenue annually by his drug Lipitor, but the loss happened in 2011 because of the expiry. Kindler described Pfizer broad pipeline of new drug and then he faced the strong balance sheet where he became the legacy and focused on the conventional medicines and declined the R&D productivity. The origin of medicines is since the late nineteen-century where Penicillin medicine was the major impact. During this period of time medical practitioners where the decision makers and were price sensitive. By 1970 there were two developments that were the Thalidomide tragedy and legislation. Generic medicines were launched at lower price with a major impact on industries,......

Words: 1567 - Pages: 7

Global Pharmaceutical Industry

.../application support costs by speeding time to issue resolution  Significant cost savings over phone-based troubleshooting  Improve helpdesk/technician productivity Fast, easy setup with automatic setting configuration:  Dynamic client delivery, cross-platform support  Automatic desktop sharing/remote control request  Secure Chatting disabled SA Series Help Desk 36 Remote assistance to any user with no software installation Employee www.radiusconsultingghana.com Copyright © 2010 Juniper Networks, Inc. www.juniper.net AGENDA 1. SSL VPN Market Overview 2. SSL VPN Use Cases 3. Access Control and AAA 4. End-to-End Security 5. Junos Pulse 6. Secure Meeting 7. Business Continuity with SSL VPN 8. Hardware, Management and High Availability 37 Copyright © 2010 Juniper Networks, Inc. www.juniper.net www.radiusconsultingghana.com RECENT UNPLANNED EVENTS - IMPACTING THE GLOBAL BUSINESS Disastrous Events Pandemic H1N1 Virus Avian/Bird Flu SARS Natural Bird Flu Earthquakes Outbreaks? Hurricanes Other Terror attacks Winter storms Social Distancing MTA Strike in NYC (Dec 05) Business Continuity Challenges  Maintain productivity Bird Flu Outbreaks?  Sustain partnerships  Continue to deliver exceptional service toAsia Quake Disaster (Dec 04) customers and partners with online collaboration  Meet government mandates for Disaster Recovery and compliance Pakistani Earthquake (Oct 05) Geographical isolation Quarantines Recent examples: Volcanic Ash Event (April ‘10...

Words: 3503 - Pages: 15

Pfizer and the Global Pharmaceutical Challenge

...Freedom Writers When she realizes that her students are living in their own personal wars, she takes the Diary of Anne Frank, Romeo and Juliet (another gangster story) to read in class. She notices that her school is segregated by race and color. So, she divides her class with a colored tape taped to the middle of the floor, and she says, “ were going to play a game, o.k.?” This activity helps them realize that they are all fighting the same battles, and are living their lives very much in common. “You’re going to have fun I promise.” Look you can work on those workbooks til the bell rings or you can play a game.” This is called the line game, I’m going to ask you a question, if that question applies to you, you step on to the line then step back away for the next question. Easy right? First q How many of you have the new Snoop Dog album? Everyone steps up to the line. How many of you have seen Boys in the Hood? Again everyone steps up to the line. How many of you live in the projects? Most of them go up to the line. How many of you know someone, a friend or relative, who was or is in juvenile hall or jail? Everyone steps up to the line. How many of you have been in juvenile hall or jail for any length of time? How many of you know where to get drugs right now? How many of you know someone in a gang? All of them step up to the line. How many of you are gang members? Noone goes up to the line, but their lying. Stand on the line if you’ve lost a friend to...

Words: 1640 - Pages: 7

Pfizer

...Current policy and strategy of Pfizer Company The Pfizer Company planning to implement the following strategies due to its lost: Strategic priorities of the merger:   Strengthens platforms for improved, consistent and stable earnings growth   (1)   Definitively address revenue loss from the loss of exclusivity from hypertension drug Lipitor; (2)   Forms broad, diversified portfolio of growth drivers; and (3)   Supports continuing progress in establishing a lower, more flexible cost base.   Drives improved performance through flexible business model   (1)   Focused, agile business units; (2)   Backed by resources, scale of global enterprise; and (3)   Significant financial resources available for investment.   Extends global health care leadership   (1)   Human, animal, consumer health; nutritionals; (2)   Primary and specialty care; (3)   Vaccines, biologics and small molecules; and (4)   Developed and emerging markets.   Enhances ability to meet unmet needs of patients, physicians and other customers   (1)   Pipeline portfolio in “invest to win” disease areas; (2)   Enhances scientific, manufacturing and pharmaceutical science capabilities; and (3)   Provides the best opportunities for world class, high performing talent.   In addition, the following strategic points will be followed:   (1)   Become a leader in biologics; (2)   Enter the vaccines market; (3)   Expand and invest to win areas; (4)   Strengthen leadership in emerging markets...

Words: 333 - Pages: 2

Pharmaceutical Industry

...Environment Environment movements are real threats for Pharmaceutical industry as these movements focus on green environments and reduce chemicals and carbon which comes from pharmaceutical industries. It is not being possible to ignore these issues as they are supposed to be practiced under United Nation charter for clean and better environment. For example Pfizer is a well reputed British Pharmaceutical company which has aims to save the environment as much as possible from chemicals, waste water which includes active pharmaceutical ingredients mixture of different compounds and carbon which comes from their pharmaceutical industries. Different strategies could be used to reduce carbon and chemical waste from drugs for human environment, like proper consumption ,good way of savages for hospitals waste water like advance waste water treatment technology, private house hold expire drugs, training and education of medical professionals to reduce over prescription, and public education and awareness. These strategies could be help full for save green house environment from drugs. In conclusion if we do focus on three principal strategies to reduce the input of chemicals compounds, carbon, and waste water in to the environment are substitution of complex chemical compounds, advance technical approach, and proper education and training of doctors, retailers and consumers. (Klaus Kümmerer, 2009) Social The social life, physical activities and level of health of a community...

Words: 1468 - Pages: 6

Walmart's Global Challenge

..., and we are rapidly scaling this work” (CorporateWalmart3, 2014, p. 5). These initiatives are good for public relations because the environment is an important issue for most people. The sustainability activities are benchmarks that measurable and verifiable by outside organizations. The e-commerce initiative opens new markets and provides growth without the side effects of large box stores getting added to landscapes. This is a positive initiative for Walmart. They are accused of being too big, so this provides an alternative that their detractors can support. VII. Strategic social challenges Lee Scott outlined a commitment to the environment in his 2005 address, which has given them an advantage and a foot forward in this important area. He outlined the leadership’s focus on improving the impact on the environment and they are working tirelessly at meeting those goals. On Walmart’s corporate home page they have a global responsibility report that covers important social challenges. It discusses their “corporate efforts related to workplace, compliance and sourcing, social and environmental responsibility” (Corporate Walmart3, 2014, p. 2). The report discusses Walmart’s progress in their various markets towards meeting the goals. VIII. Repeating the past Ghemawat, Bradley and Mark discussed issues regarding gender discrimination and wage and health care spending, and employee misuse in their case study (2004, pp. 13, 14). Those issues persisted through at...

Words: 2589 - Pages: 11

Putting It All Together a Look at Pfizer Pharmaceutical Company

... Directors makes the majority of the decisions regarding the future of the company, day to day operations and company finances. Pfizer has about 14 members serving on Board of Directors, ages varying from 52 to 72. These individuals are vital to the organization because they bring age, experience and knowledge to Pfizer’s staff. They can also be beneficial for training, coaching and giving advice to the younger employees at Pfizer. Also serving along with the Board of Directors is the Chairman of the Board and Chief Executive Officer (CEO) Mr. Ian Read, four Presidents of the company, and about eight Executive Vice Presidents. The Presidents specialize and are in charge of different fields within a wide spectrum of the company. “Fields such as Emerging Markets and Established Products, Worldwide Research and Development, Specialty Care and Oncology and Primary Care Business Unit” (Pfizer, 2013). This knowledgeable group of Presidents and Vice Presidents make up the Executive Leadership Team (ELT) they makes the decisions concerning Pfizer’s future. Together this group has on average about 25 years of knowledge and experience in the pharmaceutical industry. Good managerial leadership is essential to the development, growth and future success of a company as a whole. Pfizer engages in the vertical coordination model of management within the company starting at the top with the stakeholders. The stakeholders have a personal stake in the organization, and have multiple concerns...

Words: 5349 - Pages: 22

Industry Analysis of the Pharmaceutical Industry

... ........................................................................................................... 4 4 Conclusion ..............................................................................................................................4 II 1 Introduction The pharmaceutical industry has provided for over USD 980 billion in worldwide revenue in 2014 (Statista 2015) and has up to today been responsible for the development of over 86.000 drugs in Germany alone (vfa 2014). While the global share of the pharmaceutical industry’s gross value added remains relatively stable, the growth rate of the gross value added in absolute terms has been declining from 11% in 2007 to -0.5% in 20121. As many individuals consider health as the most valuable asset in life and hence come in frequent contact with the outcome of the pharmaceutical industry, this assignment serves the purpose of analyzing this exceptional industry by means of Porter’s Five Forces, in order to give an overview of the different factors influencing the ongoing developments in this enormous branch. By analyzing the pharmaceutical industry, this assignment seeks to ascertain the level of attractiveness of the contemplated market. 2 Theoretical framework of Porter’s Five Forces In contemplation of evaluating an industry’s attractiveness, the Porter Five Forces analysis is a useful method, which subdivides different factors influencing an industry. The two forces of bargaining......

Words: 1934 - Pages: 8